Arnould, Coline
Rocher, Vincent https://orcid.org/0000-0002-3421-482X
Saur, Florian
Bader, Aldo S. https://orcid.org/0000-0001-5760-5113
Muzzopappa, Fernando https://orcid.org/0000-0001-6420-828X
Collins, Sarah
Lesage, Emma https://orcid.org/0000-0001-7366-0171
Le Bozec, Benjamin
Puget, Nadine
Clouaire, Thomas https://orcid.org/0000-0003-3238-1496
Mangeat, Thomas
Mourad, Raphael
Ahituv, Nadav https://orcid.org/0000-0002-7434-8144
Noordermeer, Daan https://orcid.org/0000-0002-9296-7002
Erdel, Fabian https://orcid.org/0000-0003-2888-7777
Bushell, Martin
Marnef, Aline https://orcid.org/0000-0002-7023-1360
Legube, Gaƫlle https://orcid.org/0000-0002-4784-2702
Article History
Received: 7 November 2021
Accepted: 12 September 2023
First Online: 18 October 2023
Change Date: 16 November 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41586-023-06841-8
Competing interests
: N.A. is a cofounder and on the scientific advisory board of Regel Therapeutics and receives funding from BioMarin Pharmaceutical Inc. The other authors declare no competing interests.